ArticleDiscover oncology2024

GLN2 as a key biomarker and therapeutic target: evidence from a comprehensive pan-cancer study using molecular, functional, and bioinformatic analyses.

Shuang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.